BR9907847A - Agentes anti-inflamatórios seletivos para glucocorticóides - Google Patents

Agentes anti-inflamatórios seletivos para glucocorticóides

Info

Publication number
BR9907847A
BR9907847A BR9907847-3A BR9907847A BR9907847A BR 9907847 A BR9907847 A BR 9907847A BR 9907847 A BR9907847 A BR 9907847A BR 9907847 A BR9907847 A BR 9907847A
Authority
BR
Brazil
Prior art keywords
glucocorticoids
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
BR9907847-3A
Other languages
English (en)
Inventor
Michael J Coughlan
Michael E Kort
James P Edwards
Todd K Jones
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of BR9907847A publication Critical patent/BR9907847A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"AGENTES ANTI-INFLAMATóRIOS SELETIVOS PARA GLUCOCORTICóIDES" Compostos possuindo a Fórmula (I) são úteis para antagonizar, reprimir, agonizar ou modular parcial ou completamente o receptor glucocorticóide em um mamífero e tratamento de doenças imunes, autoimunes e inflamatórias em um mamífero. São também reveladas composições farmacêuticas compreendendo os compostos da Fórmula (I) e os processos para inibir doenças imunes e autoimunes em um mamífero.
BR9907847-3A 1998-02-13 1999-02-15 Agentes anti-inflamatórios seletivos para glucocorticóides BR9907847A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/023,913 US6380207B2 (en) 1998-02-13 1998-02-13 Glucocortiocoid-selective antiinflammatory agents
PCT/US1999/003210 WO1999041257A1 (en) 1998-02-13 1999-02-15 Glucocorticoid-selective antiinflammatory agents

Publications (1)

Publication Number Publication Date
BR9907847A true BR9907847A (pt) 2001-01-09

Family

ID=21817891

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907847-3A BR9907847A (pt) 1998-02-13 1999-02-15 Agentes anti-inflamatórios seletivos para glucocorticóides

Country Status (24)

Country Link
US (1) US6380207B2 (pt)
EP (1) EP1053240B1 (pt)
JP (1) JP2002503666A (pt)
KR (1) KR20010040940A (pt)
CN (1) CN1153771C (pt)
AT (1) ATE237620T1 (pt)
AU (1) AU760511B2 (pt)
BG (1) BG64213B1 (pt)
BR (1) BR9907847A (pt)
CA (1) CA2320911A1 (pt)
DE (1) DE69906938T2 (pt)
DK (1) DK1053240T3 (pt)
ES (1) ES2197618T3 (pt)
HK (1) HK1033309A1 (pt)
HU (1) HUP0100846A3 (pt)
IL (1) IL137509A0 (pt)
NO (1) NO20004052L (pt)
NZ (1) NZ506012A (pt)
PL (1) PL342999A1 (pt)
PT (1) PT1053240E (pt)
SK (1) SK284076B6 (pt)
TR (1) TR200002345T2 (pt)
WO (1) WO1999041257A1 (pt)
ZA (1) ZA99533B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
EP1201660B1 (en) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid receptor modulators
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
EP1467730A4 (en) 2002-01-22 2010-03-10 Univ California Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
KR100492913B1 (ko) * 2002-08-23 2005-06-03 주식회사 태평양 피부 감작 및 자극을 완화하는 피부 외용제 조성물
AU2003278744B2 (en) 2002-08-28 2010-07-29 Harbor Biosciences, Inc. Therapeutic treatment methods
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
AR040783A1 (es) * 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
CL2003001544A1 (es) * 2002-10-11 2005-01-07 Ligand Pharm Inc Compuestos derivados de 5-cicloalquenil-5h-cromeno[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, l
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
CA2536349A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
ATE497763T1 (de) 2003-11-21 2011-02-15 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
CA2598216C (en) 2005-06-17 2014-04-08 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
CA2620275A1 (en) 2005-08-26 2007-03-01 Thomas S. Scanlan Non-steroidal antiandrogens
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
WO2007065828A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Glucocorticoid receptor modulators as antiinflammatory agents
KR101025139B1 (ko) * 2005-12-09 2011-03-31 에프. 호프만-라 로슈 아게 항염증제로서의 프로피온아미드 화합물
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US9908182B2 (en) 2012-01-30 2018-03-06 Black & Decker Inc. Remote programming of a power tool
US8919456B2 (en) 2012-06-08 2014-12-30 Black & Decker Inc. Fastener setting algorithm for drill driver
US10011006B2 (en) 2013-08-08 2018-07-03 Black & Decker Inc. Fastener setting algorithm for drill driver

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696133A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP1382597A3 (en) 1994-12-22 2004-04-07 Ligand Pharmaceuticals, Inc. Steroid receptor modulator compounds and methods
US5693133A (en) 1995-05-10 1997-12-02 Akzo Nobel Nv Asbestos free roof coatings

Also Published As

Publication number Publication date
BG64213B1 (bg) 2004-05-31
TR200002345T2 (tr) 2000-11-21
CN1297451A (zh) 2001-05-30
NZ506012A (en) 2003-03-28
DE69906938T2 (de) 2004-02-26
DK1053240T3 (da) 2003-08-11
BG104698A (en) 2001-05-31
DE69906938D1 (de) 2003-05-22
EP1053240B1 (en) 2003-04-16
US6380207B2 (en) 2002-04-30
ZA99533B (en) 1999-07-26
KR20010040940A (ko) 2001-05-15
AU760511B2 (en) 2003-05-15
PL342999A1 (en) 2001-07-16
ATE237620T1 (de) 2003-05-15
AU2600399A (en) 1999-08-30
HK1033309A1 (en) 2001-08-24
NO20004052L (no) 2000-10-12
US20010049377A1 (en) 2001-12-06
PT1053240E (pt) 2003-09-30
JP2002503666A (ja) 2002-02-05
SK284076B6 (sk) 2004-09-08
EP1053240A1 (en) 2000-11-22
HUP0100846A2 (hu) 2001-09-28
IL137509A0 (en) 2001-07-24
CA2320911A1 (en) 1999-08-19
CN1153771C (zh) 2004-06-16
SK11962000A3 (sk) 2001-03-12
HUP0100846A3 (en) 2003-03-28
ES2197618T3 (es) 2004-01-01
WO1999041257A1 (en) 1999-08-19
NO20004052D0 (no) 2000-08-11

Similar Documents

Publication Publication Date Title
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
BR9910864A (pt) Compostos anti-inflamatórios para inibição de aderência celular
IT1214609B (it) Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
BR9811099A (pt) Inibidores de urocinase
ATE267168T1 (de) Beta-alanin-derivate als zell-adhäsions- inhibitoren
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
FI973087A0 (fi) Soluadheesion inhibiittoreita
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
BR9916638A (pt) Compostos anti-inflamatórios e imuno-supressores inibidores de aderência celular
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
PT1100483E (pt) Agentes anti-inflamatorios selectivos para glicocorticoide
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE69819539D1 (de) Antithrombotische mittel
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
NO990322L (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
EP0980366A4 (en) ANTITHROMOSIS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1945 DE 15 - 04 - 2008.